XML 14 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Statements of Income (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Income Statement [Abstract]        
Net revenue $ 492,949 $ 460,635 $ 1,412,661 $ 1,317,321
Operating expenses:        
Practice salaries and benefits 328,759 309,904 964,806 909,168
Practice supplies and other operating expenses 26,122 22,440 72,516 66,455
General and administrative expenses 66,892 66,346 204,376 194,276
Gain on sale of building (7,280)
Depreciation and amortization 8,151 7,195 24,288 20,749
Transformational and restructuring related expenses 4,232 34,291 19,042 60,846
Total operating expenses 434,156 440,176 1,277,748 1,251,494
Income from operations 58,793 20,459 134,913 65,827
Investment and other income 1,686 10,534 11,829 13,064
Interest expense (17,595) (27,250) (52,119) (83,180)
Loss on early extinguishment of debt (14,532)
Equity in earnings of unconsolidated affiliate 550 282 1,622 1,081
Total non-operating expenses (15,359) (16,434) (53,200) (69,035)
Income (loss) from continuing operations before income taxes 43,434 4,025 81,713 (3,208)
Income tax benefit (provision) (11,594) (6,677) (14,002) (10,859)
Income (loss) from continuing operations 31,840 (2,652) 67,711 (14,067)
(Loss) income from discontinued operations, net of tax (1,052) (38,392) 15,716 (718,125)
Net income (loss) 30,788 (41,044) 83,427 (732,192)
Net loss attributable to noncontrolling interest 7 21
Net income (loss) attributable to Mednax, Inc. $ 30,795 $ (41,044) $ 83,448 $ (732,192)
Income (loss) from continuing operations:        
Basic $ 0.37 $ (0.03) $ 0.80 $ (0.17)
Diluted 0.37 (0.03) 0.79 (0.17)
(Loss) income from discontinued operations:        
Basic (0.01) (0.46) 0.18 (8.62)
Diluted (0.01) (0.46) 0.18 (8.62)
Net income (loss) attributable to Mednax, Inc.:        
Basic 0.36 (0.49) 0.98 (8.79)
Diluted $ 0.36 $ (0.49) $ 0.97 $ (8.79)
Weighted average common shares:        
Basic 85,065 83,862 84,754 83,260
Diluted 86,096 83,862 85,759 83,260